Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

Gascon, Marta Isla, Dolores Cruellas, Mara Galvez, Eva M. Lastra, Rodrigo Ocariz, Maitane Paño, José Ramón Ramirez, Ariel Sesma, Andrea Torres-Ramón, Irene Yubero, Alfonso Pardo, Julián Martinez-Lostao, Luis Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?

Cells

10.3390/cells9061525 2020

2020